Clinical Trials Directory

Trials / Completed

CompletedNCT03207880

Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion Services

Piloting an Innovation to Improve the Quality of Remote Abortion Services: Incorporating Use of Multi-Level Pregnancy Tests

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
165 (actual)
Sponsor
Gynuity Health Projects · Academic / Other
Sex
Female
Age
50 Years
Healthy volunteers
Accepted

Summary

Serial use of urine multi-level pregnancy tests (MLPTs) has been shown to be a reliable and efficient strategy for excluding ongoing pregnancy after medical abortion at ≤ 63 days of gestation. This pilot project will assess whether MLPTs can enhance the quality of remote medical abortion services through enabling women to reliably ascertain their abortion outcomes at home sooner than would otherwise have been the case. safe2choose provides remote medical abortion services through the Internet (information, counselling and access to abortion pills) in a growing number of countries worldwide. safe2choose will collaborate with Gynuity Health Projects to pilot the utility of MLPTs for home follow-up as part of its remote medical abortion services. As safe2choose does not have a physical office, the location of the sponsor's office is listed in this entry as the study location. Women from the United States are NOT eligible to enroll.

Conditions

Interventions

TypeNameDescription
DEVICEMulti-level pregnancy testStudy participants will be instructed to perform a baseline MLPT immediately prior to administering the first dose of abortion medication and a second MLPT one week later to ascertain the follow-up hCG range. Any woman who obtains a stable or increasing hCG result, when comparing the baseline test result with the follow-up test result, will be instructed to contact safe2choose. Any woman who obtains a decrease in her hCG range, when comparing the baseline test result with the follow-up test result, will be informed that her abortion was a success and she is no longer pregnant.

Timeline

Start date
2017-11-01
Primary completion
2018-08-10
Completion
2018-08-10
First posted
2017-07-05
Last updated
2018-09-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03207880. Inclusion in this directory is not an endorsement.